Accessibility Screen-Reader Guide, Feedback, and Issue Reporting
This site is intended for healthcare professionals
Patient Site

About Delphinus

Dedicated to the Next Generation of Dense Breast Imaging

Impassioned Team

Delphinus is comprised of passionate individuals dedicated to developing and advancing the next generation of breast imaging technology. Our team is introducing a unique and sophisticated approach to detect breast cancer, driven forward by the thousands of women each year, who are told they have breast cancer.

Our leadership is proud to work side-by-side with this inspiring team, who are committed to improving the future of breast imaging for all women.

Our Leadership Team

+

Scott White

President And Chief Executive Officer

Scott White

President And Chief Executive Officer

Formerly, the Chief Commercialization Officer for Delphinus, Scott was appointed the President & CEO in October 2023. Scott has over 25 years of experience in the healthcare and technology industries, leading commercial and operational teams.

Prior to joining the Delphinus team, Scott was the Chief Commercial Officer of Hyperfine (HYPR), developer of a bedside neurological MRI platform, where he led the development of their commercial strategy and supported the company’s IPO in 2022. In addition, he built a global commercial business throughout North America, Europe and APAC for Rapid Micro Biosystems (RPID), the developer of the Growth Direct System, which also led to a successful IPO in 2021. Scott also spent seven years at Intuitive Surgical as a VP of Sales, where he grew revenues in excess of $200 million annually.

+

Michael Emery

Chief Financial Officer

Michael Emery

Chief Financial Officer

Michael brings 30 years of experience in financial executive leadership in the pharmaceutical and medical device industries to Delphinus. He served as CFO and COO at Tyber Medical where he aligned the company for investment and financial success, streamlined business processes, drove cost reductions and improved efficiencies. Prior to Tyber, Mr. Emery led financial executive teams at Plasma Surgical and Abbott Pharmaceuticals. His tenure at Abbott spanned decades and began when he was a member of the finance team at Solvay Pharmaceuticals where he aligned the company for acquisition by Abbott and oversaw the integration of all business units following the purchase. Before joining Delphinus, Michael consulted for multiple companies in the healthcare and medical device space to help strategize and position companies to meet and exceed short and long-term financial goals.

+

Elise Berman, MD

Medical Director

Elise Berman, MD

Medical Director

Dr. Berman is a board-certified radiologist with specialized training and expertise in breast imaging. In her more than 20-year clinical tenure she held key leadership positions including Medical Director, Breast Imaging Division Chief, and Director of Breast MRI. As a physician leader, she spearheaded the development of the region’s largest breast imaging practice, prioritizing patient-centric care and upholding the highest standards of quality. Dr. Berman’s reputation as a breast imager garnered a loyal following of patients and the respect of her fellow healthcare professionals. She is recognized by her peers as a "Top Doctor" and "Best of the Best" in her specialty.

+

Heather Rone

Vice President Of Clinical Affairs

Heather Rone

Vice President Of Clinical Affairs

Heather is an acknowledged clinical and regulatory professional with a highly successful record of first-ever accomplishments within the medical technology domain. During her nearly seven-year tenure at U-Systems. she was responsible for the development and implementation of a comprehensive global training program for the automated breast ultrasound product line, satisfying new FDA training mandates that became a model for the industry. She directed multiple prospective clinical trials in the U.S. and Europe, enrolling over 18,000 participants. This extraordinary effort and achievement culminated in the first-ever FDA approval for a breast ultrasound screening indication. Among her many firsts, she was instrumental in earning additional regulatory approvals in the U.S. and global markets. Heather has co-authored multiple publications and her research efforts have contributed to several published manuscripts in peer-reviewed journals.

+

Rama Gundlapalli

Vice President of Engineering

Rama Gundlapalli

Vice President of Engineering

Rama joined Delphinus with vast experience in commercial development and building robust product pipelines for medical device companies. Rama was the senior director of research collaborations at Siemens Healthineers where he supervised the Advanced Therapies US/Canada collaboration Team with a focus on driving leadership transformation and executing innovation and product development strategies across interventional neurology, pulmonology, cardiology, liver cancer and skeletal diseases. Prior to Siemens, Rama worked at Northgate Technologies Inc. helping develop and commercialize laparoscopic insufflators and lithotripsy systems; CareFusion (acquired by BD) and DePuy Synthes (J&J MedTech) leading the development and launch of their high-flex total knee systems. In addition, Rama has nurtured his entrepreneurial side with three startups of his own.

+

Dane Baruzzini

Vice President of Operations

Dane Baruzzini

Vice President of Operations

Dane Baruzzini is a seasoned Operations executive with over 15 years of experience in dynamic startup environments. With a robust background in building, developing, and leading Operations, Dane has consistently driven organizational success through his strategic vision and operational excellence. He is passionate about creating world class culture throughout the organization.

Prior to coming to Delphinus, Dane spent ten years in the pharmaceutical industry, where he was instrumental in developing a comprehensive global supply chain. His efforts have spanned North America, Europe, and Australia, ensuring seamless manufacturing and distribution processes that meet the stringent demands of the FDA and other governing bodies.

One of Dane's notable achievements includes the successful in-house integration of manufacturing at multiple companies. At Delphinus, he brought manufacturing in-house where his team successfully manufactured their first SoftVue systems in 2023. His expertise lies in stabilizing complex product supply chains, a skill that has proven critical in reducing costs and boosting productivity across organizations.

Co-Founders

+

Neb Duric, Ph.D.

Co-Founder and Chief Technology Officer

Neb Duric, Ph.D.

Co-Founder and Chief Technology Officer

Dr. Duric, internationally acclaimed leader of innovative scientific research in the field of ultrasound imaging, is the Chief Technology Officer of Delphinus Medical Technologies. An expert in new imaging applications, he is Co-Inventor and developer of ultrasound tomography techniques that have led to the establishment of the Delphinus SoftVue™ imaging system. Dr. Duric is currently a professor and the Vice Chair of Research in the Department of Imaging Sciences at the University of Rochester. He was formerly the Professor of Oncology at Wayne State University and served as the Co-Leader of the Molecular Imaging Program at the Karmanos Cancer Institute. He has won a number of awards including Hero of Breast Cancer from Karmanos Cancer Institute, and he has been named Innovator of the Year by the State of Michigan and received a Distinguished Innovator Award from Wayne State University.

+

Peter J. Littrup, M.D.

Co-Founder and Medical Advisor

Peter J. Littrup, M.D.

Co-Founder and Medical Advisor

Dr. Littrup is a globally-recognized scientist in medical imaging and intervention. He is a board certified radiologist and clinically active breast imager who has conducted extensive research in the domains of cancer screening, ultrasound technology, biopsy guidance, and tumor ablation. As one of the original inventors of ultrasound tomography (UST) and Medical Advisor, he gives Delphinus Medical Technologies his unique full-spectrum experience from screening to biopsy and pioneering breast cryoablation. Dr. Littrup’s vision for the broad use of UST, from screening to treatment follow-up, thereby helped solidify the overall design and testing of the Delphinus SoftVue™ imaging system. He is an Interventional Radiologist at Crittenton Hospital Medical Center, Rochester, Michigan, recruited as Director of the Tumor Ablation Program, and assists in the development of the new breast center with guidance for new technology introduction. He is Professor of Radiology and Oncology at Wayne State University and was principal investigator of the Michigan Translational Research and Commercialization effort of the Michigan Economic Development Corporation. He held the position of full professor in the Department of Diagnostic Imaging at the Warren Alpert Medical School, Brown University, as well as Director of the Human Imaging Core and Ablation Program at Karmanos Cancer Institute. Dr. Littrup Is a graduate of the University of Michigan Medical School, completed a fellowship in prostatic ultrasound at St. Joseph Mercy Hospital in Ann Arbor, Michigan, and was a Radiology Society of North America Research Fellow developing tumor ablation technology and imaging.

We use cookies to enhance user experience, analyze performance and traffic on our website, and personalize content. We also share information about your use of our website with our advertising and analytics partners. For more information on our use of cookies and information about your use of our site, please see our Privacy Policy.